Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Octim Injection

{email} Notify me of changes to this product

emc account functionality

Sign in or register for an emc account to use this functionality and much more:

  • Get the latest updates to your inbox

    Receive email notifications when chosen products are updated

  • Stay up to date with document change history

    Get full access to document change history

  • Similar product search

    Use active ingredient, company or ATC code

  • Save your regular searches

    Simple access to search enquiries every time you need them

  • Favourite products you use most often

    Helps you find products you use regularly as fast as possible

Active Ingredient:
About Medicine
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 15 Sep 2026

Below is a text only representation of the Patient Information Leaflet (ePIL).

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on {phone} 0800 198 5000. The product code(s) for this leaflet is: PL 03194/0055.

Octim Injection

Package Leaflet: Information for the Patient

Octim® 15 microgram/ml solution for Injection

Desmopressin acetate

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
  • Keep this leaflet, you may need to read it again
  • If you have any questions, ask your doctor, pharmacist or nurse
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you get any side effects get serious, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See Section 4.

What is in this leaflet:

1. What Octim Injection is and what it is used for
2. What you need to know before you use Octim Injection
3. How Octim Injection will be given
4. Possible side effects
5. How to store Octim Injection
6. Contents of the pack and other information

1. What Octim Injection is and what it is used for

Octim Injection is a clear, colourless solution. It contains Desmopressin acetate, an antidiuretic (reduces urine production).

It is used:

  • during surgery or following trauma in patients with mild to moderate haemophilia (blood condition) or von Willebrand’s disease (blood clotting condition) to increase blood clotting factors (Note: Octim Injection is not suitable for every patient or for the treatment of all types of haemophilia or von Willebrand’s disease)
  • to test for fibrinolytic response (a test to measure the capacity of the body to dissolve blood clots once they have formed)

2. What you need to know before you use Octim Injection
Do not use Octim Injection
  • if you are allergic to desmopressin acerare or any of the other ingredients of this medicine (listed in section 6)
  • if you drink unusually large amount of fluids
  • if you suffer from heart problems or other conditions requiring treatment with diuretics (water tablets)
  • if you have low blood sodium levels (hyponatremia)
  • if you suffer from syndrome of inappropriate antidiuretic hormone secretion (SIADH)
  • if you suffer from a more severe form of chest pain (unstable angina)
  • if you suffer from von Willebrand’s disease type IIb

Warnings and precautions

Talk to your doctor before taking Octim Injection.

Be extra careful with the use of Octim Injection:

  • in children, elderly patients and patients with blood sodium levels in the lower normal range, as the risk of hyponatraemia (low blood sodium levels) may be increased
  • if you suffer from a condition that causes a fluid and/or salt imbalance e.g. vomiting, diarrhoea, infections or fever
  • if you are at risk of increased intracranial pressure (pressure inside the skull)
  • if you have moderate to severe kidney dysfunction
  • if you need to be treated for bleeding several times within two days. The effect of Octim Injection may then decrease.
  • if you suffer from cardiovascular disease such as blood clots, arteriosclerosis or if you have had angioplasty (artery-opening procedure).

While using Octim Injection, your fluid intake must be limited. In this way, you will prevent fluid overload in your body and a lack of sodium in your blood.

Fluid retention (build-up of water in the body) and/or hyponatraemia (low blood sodium levels), with or without accompanying warning signs or symptoms, may occur during treatment with desmopressin (see section 4 “Possible side effects”). Contact your doctor if you notice these warning signs or symptoms; your doctor may check your weight and sodium levels.

Octim Injection does not reduce the prolonged bleeding time in thrombocytopenia (platelet deficiency).

Other medicines and Octim Injection

Tell your doctor if you are taking, have recently taken or might take any other medicines.

Octim Injection may have a stronger effect if you are already taking other medications that also affect the fluid and/or salt balance in your body. As a result, your body is more likely to retain too much fluid and your blood sodium levels might decrease.

Examples include:

  • medicines to treat very severe pain: opioids
  • medicines to treat depression: tricyclic or SSRI antidepressants
  • medicines to treat pain and/or inflammation: non-steroidal anti-inflammatory drugs, such as indomethacin, ibuprofen
  • chlorpromazine (for the treatment of psychosis or schizophrenia)
  • carbamazepine (for the treatment of epilepsy)
  • drugs to treat diabetes: sulphonylurea derivatives, such as chlorpropamide

Octim Injection with food or drink
  • you should avoid drinking large amounts of fluid while you are being treated with Octim Injection as this could lead to build up of water which dilutes the salt in the body. This is a serious problem and may lead to convulsions. You should only drink enough fluid to satisfy your thirst.
  • when used to test fibrinolytic response, limit fluid intake to a maximum of 500 ml from 1 hour before until 8 hours after the dose.

Pregnancy, breast-feeding and fertility

If you are pregnant or planning a pregnancy, please inform your doctor before you use Octim Injection as blood pressure monitoring is recommended due to the increased risk of pre-eclampsia (a condition in pregnant women that can cause serious complications). Symptoms of pre-eclampsia include high blood pressure, oedema (swelling due to the build up of fluid) and proteinuria (protein in the urine).

Breast-feeding:

If you are breast-feeding ask your doctor or pharmacist for advice before using Octim Injection.

Octim Injection contains sodium

This medicinal product contains less than 1 mmol sodium (23 mg) per dose, that is to say essentially ‘sodium-free’.

3. How Octim Injection will be given

Depending on the condition that you are being treated for, the doctor will administer the appropriate dose by injection, either just under the skin (subcutaneous) or directly into one of your veins (intravenous).

During surgery or following trauma in patients with mild to moderate haemophilia and von Willebrand’s disease to increase blood clotting factors:

The dose for adults, children and infants is 0.3 micrograms per kilogram body weight, administered just under the skin (subcutaneous) or directly into one of your veins (intravenous) over a period of 20 minutes. This dose should be given before surgery or following trauma. Further doses may be administered at 12 hourly intervals.

Fibrinolytic response test:

The dose for adults and children is 0.3 micrograms per kilogram body weight, administered just under the skin (subcutaneous) or directly into one of your veins (intravenous) over a period of 20 minutes.

If you are given more Octim Injection than you should:

As this medicine will be given to you whilst you are in hospital it is unlikely that you will be given too much, however, avoid drinking any more fluid and seek medical advice if you have any concerns.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Tell your doctor or nurse immediately if you get any of the following side effects:

The most important, severe side effect for Octim Injection is hyponatraemia (low blood sodium levels). Hyponatraemia can cause headache, nausea, vomiting, weight gain, malaise (feeling unwell), abdominal pain (stomach ache), muscle cramps, dizziness, confusion, impaired consciousness, generalised oedema (fluid accumulation in the body’s tissue) and, in severe cases, cerebral oedema (swelling of the brain), hyponatraemic encephalopathy (brain dysfunction due to fluid overload and sodium deficiency), convulsions (seizures) and coma. Very rare (may affect up to 1 in 10,000).

Cases of severe hypersensitivity reactions including anaphylactic shock and anaphylactic reaction (allergic shock and acute hypersensitivity reaction) have been reported in association with Octim Injection. These reactions can cause difficulty breathing, redness of the skin, itching, rash or hives, dizziness due to a drop in blood pressure and swelling in different parts of the body, including the face or limbs. Not known (frequency cannot be estimated from the available data).

Other side effects that might occur

Common (may affect up to 1 in 10 patients):

  • headache
  • nausea
  • abdominal pain
  • tachycardia (rapid heartbeat)1
  • flushing (reddening of the skin)1
  • hypotension (low blood pressure)1
  • tiredness

Rare (may affect up to 1 in 1,000 patients):

  • dizziness

Not known (frequency cannot be estimated from the available data):

  • cerebral ischemia (stroke)2
  • acute myocardial infarction (heart attack)2
  • blood clots in deep veins, brain or lungs3
  • angina pectoris2
  • itching
  • hives
    1. For the treatment of bleeding (high dose) at the time of administration, transient fall in blood pressure with increased heart rate and flushing.
    2. Reported in the treatment of bleeding (high dose) and only in patients with a history of, or risk factors for blood clots, heart or blood vessel disease, or if you have had performed an angioplasty (artery-opening procedure).
    3. Reported mainly in the treatment of bleeding (high dose).

Reporting of side effects

If you get any side effects, talk to your doctor or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme, website: https://yellowcard.mhra.gov.uk. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store Octim Injection

Keep this medicine out of the sight and reach of children.

Octim Injection should be stored in a refrigerator at 2°C to 8°C. Keep container in the outer carton.

Use by date: Do NOT use Octim Injection past the expiry date on the packaging. The expiry date refers to the last day of that month.

This product should only be given by a doctor or qualified nurse and will be safely disposed of by them.

6. Content of the pack and other information

Your medicine is called Octim Injection.

it is supplied in clear glass ampoules and each ampoule contains 1 ml of a clear, sterile colourless solution.

  • each 1ml of the solution contains 15 micrograms of the active ingredient Desmopressin acetate dissolved in water for injection.
  • other ingredients in Octim Injection are sodium chloride and hydrochloric acid.

Marketing Authorisation Holder
Ferring Pharmaceuticals Ltd.
Drayton Hall
Church Road
West Drayton
UB7 7PS
(UK)

Manufacturer:
FERRING GmbH
Wittland 11
Kiel
Germany

This leaflet was last revised in July 2026.

Octim, FERRING and the FERRING Logo are trademarks of Ferring.

Ferring Pharmaceuticals Ltd
Company image
Address
Drayton Hall, Church Road, West Drayton, UB7 7PS, UK
Telephone
+44 (0)844 931 0050
Fax
+44 (0)844 931 0051
Medical Information e-mail
[email protected]
Customer Care direct line
0800 111 4126